跳至主要内容
临床试验/NCT00994734
NCT00994734已完成不适用

Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

Gynuity Health Projects7 个研究点 分布在 3 个国家目标入组 615 人开始时间: 2009年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
615
试验地点
7
主要终点
Proportion of women who select home-use of mifepristone

研究概览

简要总结

The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Reproductive age women seeking abortion services.
  • Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken.
  • Participants must be eligible for medical abortion according to clinician and clinic standards.
  • In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.

排除标准

  • 未提供

研究组 & 干预措施

home administration of mifepristone

Experimental

干预措施: Mifepristone (Drug)

结局指标

主要结局

Proportion of women who select home-use of mifepristone

时间窗: 1-2 weeks

Satisfaction with Method

时间窗: 1-2 weeks

次要结局

未报告次要终点

研究者

发起方
Gynuity Health Projects
申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验